comprehensive -WSS

comprehensive

author：explore 2025-08-23 03:40:21 - browse：61

Photo illustration of Chris Viehbacher -- biotech coverage from STAT — Chris Viehbacher took over as Biogen CEO in November. Suzanne Kreiter/Globe staff; Photo illustration Alex Hogan/STAT

This was supposed to be the new Biogen. When Chris Viehbacher, a respected pharmaceutical executive, took over as CEO in November, Wall Street saw him as a steadying force for the wayward company and a strong personality who would stand up to its quarrelsome board.

Instead, Biogen’s board has saddled Viehbacher with the first crisis of his tenure at the company. Alex Denner, a long-time director, nominated a biotech executive who is also the mother of his child to succeed him on the board, and Biogen chose not to disclose the couple’s relationship to shareholders, an omission that shocked people close to the company and undermined the notion that Biogen was changing for the better.

“It’s just disappointing to see after all the criticism that has been levied at the company over the last few years, there really seems to be no self-awareness going into this recommendation,” said Brian Skorney, a securities analyst at Baird who covers Biogen.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Medicare drug price negotiation’s day in court

WSS

Readout Newsletter: Vertex, Biogen's Aduhelm, and Bristol updates

Biohaven protein

Novo Nordisk to expand supply of Wegovy for U.S. patients

iTeos Therapeutics debuts first data on TIGIT

Juul spent big to court Black leaders to promote its e

Vertex non

focus

comprehensive

leisure time

Wildfire smoke exposes gaps in outdoor worker protections

Startling documents reveal new facets of Sacklers' opioid empire

Medicare proposal to cover medical devices draws a mixed reaction

Lab trade group sues FDA to halt regulation of lab

Trump demands the U.S. pay no more for drugs than other countries … again

Stigma and the return of syphilis

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

The real point of Kenneth Smith’s execution by nitrogen gas

Alkermes shareholders re

Stigma and the return of syphilis

explore

Lab trade group sues FDA to halt regulation of lab

David Sabatini, ex

Addiction doctors spar with methadone clinics over legislation

Vertex non

The real point of Kenneth Smith’s execution by nitrogen gas

First Opinion Podcast: What happens when kids become caregivers?

knowledge

focus

focus

knowledge